MSB 0.98% $1.03 mesoblast limited

"Mesoblast plans to leverage the results from a planned US trial...

  1. 262 Posts.
    lightbulb Created with Sketch. 162
    "Mesoblast plans to leverage the results from a planned US trial to support potential product approvals
    in both US and EU".

    Educate me please. If they've had a successful Phase 3 trial, why do they need another trial?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.